Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Panax Ginseng Extract,Ginkgo Biloba,Benfotiamine | Pyridoxal 5-phosphate | L-Methyl Folate | Chromium Picolinate | Biotin | Vitamin B12
Therapeutic Area : Psychiatry/Psychology
Study Phase : Approved FDF
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Cadila Pharmaceuticals launches Nu Nutridac capsule for anxiety-related disorders
Details : Nu Nutridac, a clinically proven nutritional replenisher designed to support patients with neurodegenerative conditions and anxiety-related disorders.
Product Name : Nu Nutridac
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
September 16, 2025
Lead Product(s) : Panax Ginseng Extract,Ginkgo Biloba,Benfotiamine | Pyridoxal 5-phosphate | L-Methyl Folate | Chromium Picolinate | Biotin | Vitamin B12
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Approved FDF
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Bacopa Monnieri,Withanolide D,Ginkgo Biloba
Therapeutic Area : Neurology
Study Phase : Approved FDF
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Aayush Wellness expands nutraceutical product portfolio
Details : Brain Fuel Capsules is formulated to support cognitive function, memory retention and mental clarity using time-tested herbal ingredients.
Product Name : Brain Fuel Capsules
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
July 14, 2025
Lead Product(s) : Bacopa Monnieri,Withanolide D,Ginkgo Biloba
Therapeutic Area : Neurology
Highest Development Status : Approved FDF
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Ginkgo Biloba
Therapeutic Area : Psychiatry/Psychology
Study Phase : Phase IV
Sponsor : The First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Ginkgo Biloba is a drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Angina Pectoris-associated with Depression.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
August 27, 2020
Lead Product(s) : Ginkgo Biloba
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Phase IV
Sponsor : The First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine
Deal Size : Inapplicable
Deal Type : Inapplicable